Ardian takes majority stake in Novacap
Context
Ardian (then AXA Private Equity) entered into a definitive agreement to acquire a majority stake in Novacap from the private equity firm Bain Capital. The transaction marked the second major LBO for the chemical group since its carve-out from Rhodia in 2003. The strategic rationale for Ardian centered on transforming a primarily French-centric industrial producer into a global specialty chemical platform. The investment plan focused on two main pillars: accelerating international expansion and diversifying the product mix toward high-growth pharmaceutical and health markets. This transition aimed to reduce the group's exposure to cyclical commodity chemicals in favor of more stable, high-margin specialty ingredients.
By taking control of Novacap, Ardian continues its expansion strategy. Previously, the group had completed 2 acquisitions, including Diana Group in 2007.
Novacap, which reported an EBITDA margin of [members only] in 2010, is valued in this transaction at an EV/EBITDA multiple of 5x–12x.
-> Deep-dive in Industry & Manufacturing market trends
Target
Novacap is an international specialty chemicals group headquartered in Lyon, France, specializing in the production and distribution of essential chemical ingredients. The organization is a global leader across diversified end-markets, including pharmaceuticals, healthcare, cosmetics, fragrances, food, animal nutrition, and environmental services. Its extensive product portfolio includes active pharmaceutical ingredients (APIs) such as aspirin and paracetamol, as well as salicylic acid, soda ash, sodium bicarbonate, and oxygenated solvents. The business model transitioned from a France-centric operation to a global platform with 14 production facilities worldwide and a workforce of 1,600 people, half of whom are based in Asia. Organized into three divisions—Mineral Specialties, Pharmaceutical & Cosmetics, and Performance Chemicals—the group serves over 750 clients globally, emphasizing sustainable development and high-value chemical synthesis for mission-critical consumer products.
Ent. Value
€300–700M
Equity Value
[members only]
Multiples
EV / Revenue
below 1.5x
EV / EBITDA
5x–12x
EV / EBIT
[members only]
Historical Financials (EUR)
Other operations with Novacap
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 04/2016 | EURAZEO / MERIEUX EQUITY PARTNERS | NOVACAP | FRANCE | Specialty Chemicals |
Other operations with Ardian
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 07/2016 | ARDIAN | DEDALUS | ITALY | Healthcare |
| 06/2016 | ARDIAN | DIAM | FRANCE | Marketing & Events |
| 04/2016 | ARDIAN | TRIGO | FRANCE | TIC (Testing, Inspection, Certification) |
| 10/2015 | ARDIAN | SOLINA GROUP | FRANCE | Ingredients |
| 07/2015 | ARDIAN | IRCA | ITALY | Ingredients |
| 02/2015 | ARDIAN | SIACI SAINT-HONORE | FRANCE | Brokerage |
| 01/2014 | ARDIAN | NHV GROUP | BELGIUM | Transport & Logistics |
| 10/2013 | ARDIAN | LABORATOIRES ANIOS | FRANCE | Medical Consumables |
| 06/2007 | ARDIAN | DIANA GROUP | FRANCE | Ingredients |
| 10/2006 | ARDIAN | GERFLOR | FRANCE | Flooring |
Similar deals in Chemicals & Materials
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 04/2014 | MBO+ | COSMOGEN | FRANCE | Packaging & Containers |
| 02/2014 | AUTAJON | FINCARTA | ITALY | Paper & Cardboard |
| 12/2013 | ASTORG | KERNEOS | FRANCE | Construction Materials |
| 06/2013 | CINVEN | CERAMTEC | GERMANY | Glass & Ceramics |
| 11/2011 | DENTRESSANGLE | CHEMICA | FRANCE | Plastics |
| 02/2011 | ICG | GERFLOR | FRANCE | Flooring |
| 01/2010 | OAKTREE CAPITAL MANAGEMENT | VERESCENCE | FRANCE | Glass Packaging |
| 10/2006 | ARDIAN | GERFLOR | FRANCE | Flooring |
| 01/2006 | WENDEL | MATERIS | LUXEMBOURG | Construction Materials |
| 09/2003 | LBO FRANCE | MATERIS | LUXEMBOURG | Construction Materials |
REFERENCES
Valuation range: EV €300–700M
Revenue range: €250–500M
EBITDA range: €25–50M
EV/Revenue range: below 1.5x
EV/EBITDA range: 5x - 12x
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of Novacap by Ardian are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.
FAQ
What transaction does this page cover?
How was the acquisition of Novacap by Ardian valued, and what multiples were paid?
What were Novacap’s revenue and EBITDA at the time of the deal?
What sources support the information on this transaction?
What is mynth?